Xiao Ping Jin
Chief Tech/Sci/R&D Officer at SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
Profile
Xiao Ping Jin is currently the Chief Medical Officer & Deputy General Manager at Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Prior to this, he worked as a Scientific Director at AstraZeneca PLC and NASDAQ OMX Group, Inc. from 2014 to 2017.
He also served as the Vice President at Akeso, Inc. from 2020 to 2021.
Dr. Jin received his undergraduate degree from Nanjing University in 1997, his graduate degree from Washington State University in 2001, and his doctorate from the University of Minnesota School of Public Health in 2005.
Xiao Ping Jin active positions
| Companies | Position | Start |
|---|---|---|
| SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. | Chief Tech/Sci/R&D Officer | 06/09/2021 |
Former positions of Xiao Ping Jin
| Companies | Position | End |
|---|---|---|
| AKESO, INC. | Corporate Officer/Principal | 01/08/2021 |
| ASTRAZENECA PLC | Chief Tech/Sci/R&D Officer | 01/04/2017 |
NASDAQ OMX Group, Inc.
 NASDAQ OMX Group, Inc. Financial ConglomeratesFinance NASDAQ OMX Group, Inc. provides investment services. | Chief Tech/Sci/R&D Officer | 01/04/2017 |
Training of Xiao Ping Jin
| Nanjing University | Undergraduate Degree |
| Washington State University | Graduate Degree |
| University of Minnesota School of Public Health | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| AKESO, INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. | Health Technology |
| Private companies | 1 |
|---|---|
NASDAQ OMX Group, Inc.
NASDAQ OMX Group, Inc. Financial ConglomeratesFinance NASDAQ OMX Group, Inc. provides investment services. | Finance |
- Stock Market
- Insiders
- Xiao Ping Jin
